Press Releases

WASHINGTON, May 22 – Today, Senator Bernie Sanders (I-Vt.) and Representative Barbara Lee (D-Calif.) introduced the Inclusive Prosperity Act along with Senator Kirsten Gillibrand (D-N.Y.) and more than a dozen House Democrats. The legislation imposes a tax of a fraction of a percent on the trades of stocks, bonds, and derivatives. This tax on Wall Street speculation, also known as

WASHINGTON, May 21 – Sen. Bernie Sanders (I-Vt.) led a bicameral group of lawmakers in introducing the Opioid Crisis Accountability and Results Act, as Vermont Attorney General T. J. Donovan announced a lawsuit today against former Purdue Pharma CEO Richard Sackler and seven family members who served on Purdue’s Board of Directors for deliberately misrepresenting the risks of the drug

WASHINGTON, May 15—Senator Bernie Sanders (I-Vt.) led a letter with eight of his Senate colleagues to Ed Bastian, CEO of Delta Air Lines, condemning the corporation’s “insulting and demeaning” anti-union campaign targeting 40,000 of its employees. Sanders was joined by Senators Sherrod Brown (D-OH), Bob Casey (D-PA), Ron Wyden (D-OR), Tammy Baldwin (D-WI), Richard Blumenthal (D-CT), Ed Markey (D-MA), Elizabeth

WASHINGTON, May 14 – In response to news reports that the Department of Defense presented the Trump Administration with a military plan that proposes sending as many as 120,000 troops to the Middle East to counter Iran, Senator Sanders (I-Vt,) issued a live address, streamed on Facebook and Twitter: “Let me be as clear as I can be: a war

WASHINGTON, May 9 – Sen. Bernie Sanders (I-VT) and Rep. Alexandria Ocasio-Cortez (D-NY) unveiled new legislation, The Loan Shark Prevention Act, to combat the predatory lending practices of America’s big banks and protect consumers who are burdened with exorbitant credit-card interest rates. The legislation imposes a 15-percent federal cap on interest rates and empowers individual states to establish lower limits.

WASHINGTON, May 8 – Senator Sanders released the following statement in response to news that the U.S. Food and Drug Administration approved treatment for pediatric Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder. In February, Sanders sent a letter to the CEO of Catalyst Pharmaceuticals, demanding an explanation for its decision to set the price of its drug, Firdapse, at $375,000 a year. “This